| 臺大學術典藏 |
2020-12-18T08:37:37Z |
Predictors of failure of conservative treatment among patients with emphysematous pyelonephritis
|
Pu Y.-S.; Lu Y.-C.; Chiang B.-J.; Pong Y.-H.; Huang K.-H.; PO-REN HSUEH; Huang C.-Y. |
| 臺大學術典藏 |
2020-11-27T08:14:49Z |
Combined cytotoxic effects of tamoxifen and chemotherapeutic agents on bladder cancer cells: A potential use in intravesical chemotherapy
|
Pu Y.-S.;Hsieh T.-S.;Cheng A.-L.;Tseng N.-F.;Su I.-J.;Chang-Yao Hsieh;Lai M.-K.;Tsai T.-C.; Pu Y.-S.; Hsieh T.-S.; Cheng A.-L.; Tseng N.-F.; Su I.-J.; CHANG-YAO HSIEH; Lai M.-K.; Tsai T.-C. |
| 臺大學術典藏 |
2020-11-27T08:14:49Z |
Expression of mdr-1 gene in transitional cell carcinoma and its correlation with chemotherapy response
|
Pu Y.-S.;Tsai T.-C.;Cheng A.-L.;Tsai C.-Y.;Tseng N.-F.;Su I.H.-J.;Chang-Yao Hsieh;Lai M.-K.; Pu Y.-S.; Tsai T.-C.; Cheng A.-L.; Tsai C.-Y.; Tseng N.-F.; Su I.H.-J.; CHANG-YAO HSIEH; Lai M.-K. |
| 臺大學術典藏 |
2020-11-27T08:14:46Z |
Megestrol acetate antagonizes cisplatin cytotoxicity
|
Pu Y.-S.;Cheng A.-L.;Chen J.;Guan J.-Y.;Lu S.-H.;Lai M.-K.;Chang-Yao Hsieh; Pu Y.-S.; Cheng A.-L.; Chen J.; Guan J.-Y.; Lu S.-H.; Lai M.-K.; CHANG-YAO HSIEH |
| 臺大學術典藏 |
2020-11-27T08:14:42Z |
Characterization of chemoresistance mechanisms in a series of cisplatin-resistant transitional carcinoma cell lines
|
Hour T.-C.;Chen J.;Huang C.-Y.;Guan J.-Y.;Lu S.-H.;Chang-Yao Hsieh;Pu Y.-S.; Hour T.-C.; Chen J.; Huang C.-Y.; Guan J.-Y.; Lu S.-H.; CHANG-YAO HSIEH; Pu Y.-S. |
| 臺大學術典藏 |
2020-11-27T08:14:40Z |
Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions
|
Chen A.-L.;Hsu C.-H.;Lin J.-K.;Hsu M.-M.;Ho Y.-F.;She T.-S.;Ko J.-Y.;Lin J.-T.;Lin B.-R.;Wu M.-S.;Yu H.-S.;Jee S.-H.;Chen G.-S.;Chen T.-M.;Chen C.-A.;Lai M.-K.;Pu Y.-S.;Pan M.-H.;Wang Y.-J.;Tsai C.-C.;Chang-Yao Hsieh; Chen A.-L.; Hsu C.-H.; Lin J.-K.; Hsu M.-M.; Ho Y.-F.; She T.-S.; Ko J.-Y.; Lin J.-T.; Lin B.-R.; Wu M.-S.; Yu H.-S.; Jee S.-H.; Chen G.-S.; Chen T.-M.; Chen C.-A.; Lai M.-K.; Pu Y.-S.; Pan M.-H.; Wang Y.-J.; Tsai C.-C.; CHANG-YAO HSIEH |
| 臺大學術典藏 |
2020-11-27T03:25:07Z |
Quantitative analysis of messenger ribonucleic acid encoding natriuretic peptide receptors in aldosterone-producing adenoma
|
Chen Y.-M.;Wu K.-D.;Kuan-Yu Hung;Pu Y.-S.;Hsieh B.-S.; Chen Y.-M.; Wu K.-D.; KUAN-YU HUNG; Pu Y.-S.; Hsieh B.-S. |
| 臺大學術典藏 |
2020-11-19T03:20:28Z |
RBMY, a male germ cell-specific RNA-binding protein, activated in human liver cancers and transforms rodent fibroblasts
|
Tsuei D.-J.;Hsu H.-C.;Po-Huang Lee;Jeng Y.-M.;Pu Y.-S.;Chen C.-N.;Lee Y.-C.;Chou W.-C.;Chang C.-J.;Ni Y.-H.;Chang M.-H.; Tsuei D.-J.; Hsu H.-C.; PO-HUANG LEE; Pu Y.-S.; Chen C.-N.; Lee Y.-C.; Chou W.-C.; Chang C.-J.; Ni Y.-H.; Chang M.-H.; Jeng Y.-M. |
| 臺大學術典藏 |
2020-11-02T02:05:31Z |
Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions
|
Hsieh C.-Y.; She T.-S.; Ko J.-Y.; Lin J.-T.; Lin B.-R.; MING-SHIANG WU; Yu H.-S.; Jee S.-H.; Chen G.-S.; Chen T.-M.; Chen C.-A.; Lai M.-K.; Pu Y.-S.; Pan M.-H.; Wang Y.-J.; Tsai C.-C.; Ho Y.-F.; Hsu M.-M.; Lin J.-K.; Hsu C.-H.; Chen A.-L. |
| 臺大學術典藏 |
2020-09-28T07:04:45Z |
Clinical outcomes in patients undergoing laparoscopic adrenalectomy for unilateral aldosterone producing adenoma: Partial versus total adrenalectomy
|
Chen S.-F.; Chueh S.-C.; Wang S.-M.; Pu Y.-S.; Wu K.-D.; Huang K.-H. |
| 臺大學術典藏 |
2020-08-13T05:24:19Z |
Case report
|
Lin C.-C.; JANN-YUAN WANG; Pu Y.-S. |
| 臺大學術典藏 |
2020-05-26T09:27:21Z |
Acute encephalopathy following arsenic trioxide for metastatic urothelial carcinoma
|
Chih-Hsin Yang;Cheng A.-L;Keng H.-Y;Hsu C.-H;Pu Y.-S;Lin C.-C; Lin C.-C; Pu Y.-S; Hsu C.-H; Keng H.-Y; Cheng A.-L; CHIH-HSIN YANG |
| 臺大學術典藏 |
2020-05-25T07:35:36Z |
A pilot study of AFL-T (doxorubicin, 5-fluorouracil, leucovorin, and tamoxifen) combination chemotherapy for hormone-refractory prostate cancer
|
Pu Y.-S.;Cheng A.-L;Tsai T.-C;Chen J;Hsu C.-H;Chia-Chi Lin; Chia-Chi Lin; Hsu C.-H; Chen J; Tsai T.-C; Cheng A.-L; Pu Y.-S. |
| 臺大學術典藏 |
2020-05-25T07:35:35Z |
Epidermal growth factor receptor inhibitor (PD168393) potentiates cytotoxic effects of paclitaxel against androgen-independent prostate cancer cells
|
Hour T.-C.;Lin S.-R;Guan J.-Y;Chia-Chi Lin;Huang C.-Y;Liu G.-Y;Wang C.-W;Hsieh M.-W;Pu Y.-S; Pu Y.-S; Hsieh M.-W; Wang C.-W; Liu G.-Y; Huang C.-Y; Chia-Chi Lin; Guan J.-Y; Lin S.-R; Hour T.-C. |
| 臺大學術典藏 |
2020-05-25T07:35:35Z |
Differential expression of molecular markers in arsenic- and non-arsenic-related urothelial cancer
|
Hour T.-C; Pu Y.-S; Chia-Chi Lin; Huang S.-W; Chen J; Chiu A.W; Chen C.-J; Huang C.-Y. |
| 臺大學術典藏 |
2020-05-25T07:35:35Z |
Characterization of molecular events in a series of bladder urothelial carcinoma cell lines with progressive resistance to arsenic trioxide
|
Pu Y.-S.;Lee J.-M;Guan J.-Y;Chen J;Chia-Chi Lin;Huang C.-Y;Hour T.-C; Hour T.-C; Huang C.-Y; Chia-Chi Lin; Chen J; Guan J.-Y; Lee J.-M; Pu Y.-S. |
| 臺大學術典藏 |
2020-05-25T07:35:35Z |
Changing trends of prostate cancer in Asia
|
Chen J.;Huang K.-H;Huang C.-Y;Chia-Chi Lin;Chiang H.-S;Pu Y.-S; Pu Y.-S; Chiang H.-S; Chia-Chi Lin; Huang C.-Y; Huang K.-H; Chen J. |
| 臺大學術典藏 |
2020-05-25T07:35:34Z |
Complete response of urothelial carcinoma to chemotherapy in renal allograft recipients: A two-case study
|
Pu Y.-S.;Hsu C.-H;Chia-Chi Lin; Chia-Chi Lin; Hsu C.-H; Pu Y.-S. |
| 臺大學術典藏 |
2020-05-25T07:35:34Z |
Weekly cisplatin plus infusional high-dose 5-fluorouracil and leucovorin (P-HDFL) for metastatic urothelial carcinoma: An effective regimen with low toxicity
|
Pu Y.-S.;Vogelzang N.J;Chen J;Cheng A.-L;Huang C.-Y;Hsu C.-H;Chia-Chi Lin; Chia-Chi Lin; Hsu C.-H; Huang C.-Y; Cheng A.-L; Chen J; Vogelzang N.J; Pu Y.-S. |
| 臺大學術典藏 |
2020-05-25T07:35:33Z |
Gemcitabine and ifosfamide as a second-line treatment for cisplatin-refractory metastatic urothelial carcinoma: A phase II study
|
Chia-Chi Lin; Hsu C.-H; Huang C.-Y; Keng H.-Y; Tsai Y.-C; Huang K.-H; Cheng A.-L; Pu Y.-S. |
| 臺大學術典藏 |
2020-05-25T07:35:33Z |
Prognostic Factors for Metastatic Urothelial Carcinoma Treated with Cisplatin and 5-Fluorouracil-Based Regimens
|
Chia-Chi Lin; Hsu C.-H; Huang C.-Y; Tsai Y.-C; Huang K.-H; Cheng A.-L; Pu Y.-S. |
| 臺大學術典藏 |
2020-05-25T07:35:33Z |
Phase II Trial of Weekly Paclitaxel, Cisplatin Plus Infusional High Dose 5-Fluorouracil and Leucovorin for Metastatic Urothelial Carcinoma
|
Chia-Chi Lin; Hsu C.-H; Huang C.-Y; Cheng A.-L; Vogelzang N.J; Pu Y.-S. |
| 臺大學術典藏 |
2020-05-25T07:35:32Z |
Systemic therapy for metastatic urothelial carcinoma
|
Chia-Chi Lin; Hsu C.-H; Pu Y.-S; Vogelzang N.J. |
| 臺大學術典藏 |
2020-05-25T07:35:32Z |
Weekly paclitaxel and high-dose 5-fluorouracil plus leucovorin in hormone-refractory prostate cancer: In vitro combined effects and a Phase II trial
|
Chia-Chi Lin; Hsu C.-H; Hour T.-C; Cheng A.-L; Huang C.-Y; Huang K.-H; Chen J; Pu Y.-S. |
| 臺大學術典藏 |
2020-05-25T07:35:31Z |
Down-regulated expression of RhoA in human conventional renal cell carcinoma
|
Hour T.-C.;Wu W.-J;Chia-Chi Lin;Shun C.-T;Kang W.-Y;Huang C.-Y;Kuo Y.-Z;Liu G.-Y;Wang C.-W;Pu Y.-S; Pu Y.-S; Wang C.-W; Liu G.-Y; Kuo Y.-Z; Huang C.-Y; Kang W.-Y; Shun C.-T; Chia-Chi Lin; Wu W.-J; Hour T.-C. |
